Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001384101-22-000096
Filing Date
2022-06-16
Accepted
2022-06-16 20:12:18
Documents
2
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165542471995449.html 4  
1 FORM 4 wf-form4_165542471995449.xml 4 3408
2 EXHIBIT 24 - MUNA BHANJI 03-18-2022 ex-24.htm EX-24 3869
  Complete submission text file 0001384101-22-000096.txt   8771
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Issuer) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address C/O CYTOKINETICS, INCORPORATED 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Bhanji Muna (Reporting) CIK: 0001846905 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36156 | Film No.: 221022056